Combined Habit Reversal Training and Acceptance and CommitmentTherapy for Treatment of Tics in Tourette Syndrome

Not Applicable

Completed

• Conditions: Tourette Syndrome; Tic disorder; Neurological - Other neurological disorders

• Registration Number: ACTRN12623000824662
• Lead Sponsor: Perron Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-08-25
• Study Start: 2023-08-01
• Last Update Posted: 7 August 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• Adults aged 16 years and over
• Diagnosis of Tourette Syndrome or another Chronic Tic Disorder
• Comorbidities such as obsessive-compulsive disorder (OCD), anxiety disorders and Attention-Deficit Hyperactivity Disorder (ADHD) will be permitted providing that the tics are the primary concern for the participant and the co-occurring disorder is stable.

Exclusion Criteria

Moderate to severe cognitive dysfunction
• Severe psychiatric condition (such as severe depression, psychosis, suicidality or substance abuse)
• Other medical or neurological comorbidities that may interfere with treatment
• History of 4 or more sessions of a similar behavioural therapy for tics (to ensure the participant is naïve to the treatment techniques)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Yale Global Tic Severity Scale[Pre-treatment (baseline)<br>Immediately post-completion of treatment program<br>3 months post-completion of treatment program<br>6 months post-completion of treatment program<br>9 months post-completion of treatment program<br>12 months post-completion of treatment program]